Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The IBD interactome: an integrated view of aetiology, pathogenesis and therapy
Heitor Siffert Pereira de Souza, Claudio Fiocchi, Dimitrios Iliopoulos
Nature Reviews Gastroenterology & Hepatology (2017) Vol. 14, Iss. 12, pp. 739-749
Closed Access | Times Cited: 384

Showing 1-25 of 384 citing articles:

The Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis
Bruno Bonaz, Thomas Bazin, Sonia Pellissier
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 986
Clinical epigenetics: seizing opportunities for translation
María Berdasco, Manel Esteller
Nature Reviews Genetics (2018) Vol. 20, Iss. 2, pp. 109-127
Closed Access | Times Cited: 436
IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting
Alexander R. Moschen, Herbert Tilg, Tim Raine
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 16, Iss. 3, pp. 185-196
Closed Access | Times Cited: 399
NEK7 interacts with NLRP3 to modulate the pyroptosis in inflammatory bowel disease via NF-κB signaling
Xueliang Chen, Ganglei Liu, Yuanyuan Yuan, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 12
Open Access | Times Cited: 313
Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: a systematic analysis based on the Global Burden of Disease Study 2019
Rui Wang, Zhaoqi Li, Shaojun Liu, et al.
BMJ Open (2023) Vol. 13, Iss. 3, pp. e065186-e065186
Open Access | Times Cited: 283
Systematic assessment of secondary bile acid metabolism in gut microbes reveals distinct metabolic capabilities in inflammatory bowel disease
Almut Heinken, Dmitry A. Ravcheev, Federico Baldini, et al.
Microbiome (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 278
Mitochondrial function — gatekeeper of intestinal epithelial cell homeostasis
Eva Rath, Antonio Moschetta, Dirk Haller
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 15, Iss. 8, pp. 497-516
Closed Access | Times Cited: 245
Gut stem cell necroptosis by genome instability triggers bowel inflammation
Ruicong Wang, Hongda Li, Jianfeng Wu, et al.
Nature (2020) Vol. 580, Iss. 7803, pp. 386-390
Closed Access | Times Cited: 228
Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets
Patrícia Teixeira Santana, Siane Lopes Bittencourt Rosas, Beatriz Elias Ribeiro, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3464-3464
Open Access | Times Cited: 192
Intestinal Epithelial Cell Autophagy Is Required to Protect against TNF-Induced Apoptosis during Chronic Colitis in Mice
Johanna Pott, Agnieszka M. Kabat, Kevin J. Maloy
Cell Host & Microbe (2018) Vol. 23, Iss. 2, pp. 191-202.e4
Open Access | Times Cited: 182
The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics
Carlos R. Cámara-Lemarroy, Luanne M. Metz, Jonathan B. Meddings, et al.
Brain (2018) Vol. 141, Iss. 7, pp. 1900-1916
Open Access | Times Cited: 168
Luteolin alleviates inflammation and modulates gut microbiota in ulcerative colitis rats
Bolin Li, Pengli Du, Yao Du, et al.
Life Sciences (2021) Vol. 269, pp. 119008-119008
Open Access | Times Cited: 167
Main active components of Jiawei Gegen Qinlian decoction protects against ulcerative colitis under different dietary environments in a gut microbiota-dependent manner
Qinmei Li, Yao Cui, Baichang Xu, et al.
Pharmacological Research (2021) Vol. 170, pp. 105694-105694
Closed Access | Times Cited: 155
The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases
Farideh Hosseinkhani, Almut Heinken, Ines Thiele, et al.
Gut Microbes (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 151
Stress Triggers Flare of Inflammatory Bowel Disease in Children and Adults
Yue Sun, Li Lü, Runxiang Xie, et al.
Frontiers in Pediatrics (2019) Vol. 7
Open Access | Times Cited: 147
Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease
Ángela Saéz, Raquel Gómez-Bris, Beatriz Herrero‐Fernández, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7618-7618
Open Access | Times Cited: 135
Multiomics to elucidate inflammatory bowel disease risk factors and pathways
Manasi Agrawal, Kristine H. Allin, Francesca Petralia, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 19, Iss. 6, pp. 399-409
Open Access | Times Cited: 127
Mechanisms of mucosal healing: treating inflammatory bowel disease without immunosuppression?
Eduardo J. Villablanca, Katja Selin, Charlotte Hedin
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 19, Iss. 8, pp. 493-507
Closed Access | Times Cited: 127
New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology
María D. Giraldez, David Carneros, Christoph Garbers, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 11, pp. 787-803
Closed Access | Times Cited: 114
CD4 T-Cell Subsets and the Pathophysiology of Inflammatory Bowel Disease
Raquel Gómez-Bris, Ángela Saéz, Beatriz Herrero‐Fernández, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2696-2696
Open Access | Times Cited: 111
The therapeutic potential of stem cell-derived exosomes in the ulcerative colitis and colorectal cancer
Gang Guo, Zhaobang Tan, Yaping Liu, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 78
Personalized redox medicine in inflammatory bowel diseases: an emerging role for HIF-1α and NRF2 as therapeutic targets
Arno R. Bourgonje, Damian Klóska, Anna Grochot-Przęczek, et al.
Redox Biology (2023) Vol. 60, pp. 102603-102603
Open Access | Times Cited: 60
Global, regional, and national burden of 10 digestive diseases in 204 countries and territories from 1990 to 2019
Rui Wang, Zhaoqi Li, Shaojun Liu, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 49
Navigating the complexities of drug development for inflammatory bowel disease
Sailish Honap, Vipul Jairath, Silvio Danese, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 7, pp. 546-562
Closed Access | Times Cited: 32
Antimicrobial peptide DP7 alleviates dextran sulfate sodium (DSS)‐induced colitis via modifying gut microbiota and regulating intestinal barrier function
Binyan Zhao, Hongyou Zhou, Ke Lin, et al.
MedComm (2025) Vol. 6, Iss. 2
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top